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• Knowledge Gap: Myths and misconception about buprenorphine 
• State-funded Insurance: Complex administrative processes
Facilitators:
§ Post-COVID-19 policy changes to support telehealth




q Indiana lags in adopting MAT compared to many other states in the Midwest (Ray et al., 
2017).
q This ongoing qualitative study uses medical (72.4%) and non-medical (27.6%) providers’ 
narratives to explore barriers and facilitators of buprenorphine – an approved Medication 
Assisted Treatment (MAT).
q 29 semi-structured interviews were conducted via Zoom and phone. 
q Population of six rural counties from which participants were sampled ranged from 
192,000 –192,939 (County Health Ranking Road Map, 2020).
q Data analysis was conducted using inductive coding that included open, axial, and 
thematic coding.
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§ Conceptualization of MAT as drug only 
rather than a combination of 
pharmacology treatment and therapy.
“So, it’s abstinence based.  And a 
lot of people in those programs 
will say that you’re not clean." 
§ Preferred pathways to recovery:
Certain individuals are making the 
decision as to what “clean” and “recovery” 
should look like.
Risk compensation: resale and misuse of 
buprenorphine
“There’s a lot of fear of misuse of 
the medication, which can be very 
stigmatizing.”
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(Cont’d) Results: Barriers 
Theme Sub-themes Quotes
Perceived bias about SUD 
misuse
Fear of increased visibility of 
SUD in communities 
“ Not In My Backyard… people 
that will want to start a drug 
treatment program and people 
will automatically feel that their 
property values are going to go 
down.”
Complex insurance navigation for 
providers and clients 
§ Strict administrative 
requirements 
§ Added responsibilities for 
providers 
“[A] lot of them are living kind 
of in poverty, because they 
know if they go and get 
employment – if they gain 
employment, then they could 
lose it.”
INDIANA UNIVERSITY BLOOMINGTON





§ Joint messaging and campaigns 
about SUD
“… recovery community, themselves, 
have been the ones that have 
strengthened our recovery 
community.”
Insurance program 
provides a pathway to 
consistent treatment 
and recovery
§ Affordability: rural residents have 
low income 
“Oh, significantly.  I think – I think 
almost all of the clients I refer to MAT 
are on HIP.”
Increased accessibility 
to patients via 
Telehealth
§ Telehealth has helped in 
addressing transportation 
challenges 
“[W]e had to go to a lot of virtual 
options, which has been a 




Further research should focus on the consistent, recurring theme that the 
core barrier for adoption of buprenorphine in rural Indiana is the 
misconception of MAT.
There was a supplemental concern that county- and state-level health 
systems and infrastructure are not set up to support treatment of Substance 
Use Disorder or mental health.
Researchers might also benefit from focusing on facilitators and how they 
can be used to address barriers – especially how multi-organizational teams 
can support evidence-based perception of MAT.
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